The CPT codes used for screening mammography:
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
What are insurance billing codes for additional breast screening tests?TestCPT Code2D Mammogram (screening)77067 (both breasts, 2-views of each)2D Mammogram (diagnostic)77065 (one breast) 77066 (both breasts)3D Mammogram /tomosynthesis (screening)77067 (2D both breasts) + 77063 (3D both breasts )6 more rows•Nov 3, 2021
NOTE: Mammograms will not interfere with your ICD or S-ICD. However, your device could be damaged if it gets compressed in the mammogram machine. Make sure the doctor or technician knows you have an implanted device.
An ICD-10-CM diagnosis code(s) should be linked to the appropriate CPT mammography code reported. The proper diagnosis code to report would be Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast.
ICD-9 Code V76. 12 -Other screening mammogram- Codify by AAPC.
2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R92. 2 became effective on October 1, 2021.
Mammograms will not cause interference with your implanted heart device. You may want to advise the center where the test is being performed that you have an implanted heart device.
The mammogram must comply with the highest standards regarding technical image quality criteria. This also applies to females with an implanted medical device (IMD) located in the breast, such as an implantable cardioverter defibrillator (ICD), pacemaker, heart rhythm monitor or port-a-cath.
A word of caution to women with a pacemaker or implanted cardioverter/defibrillator (ICD): When you have a mammogram, make sure the technologist doing the scan knows that you have a device to regulate your heart.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
Encounter for other screening for malignant neoplasm of breast. Z12. 39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z1231 - Encounter for screening mammogram for malignant neoplasm of breast - as a primary or secondary diagnosis code . Total National Projected Hospitalizations - Annualized (Present on Admission - All)
77065, Diagnostic mammography, including CAD when performed; unilateral. 77066, Diagnostic mammography, including CAD when performed; bilateral. In a perfect world, the new CPT codes would result in uniform coding of mammography services.
Z12. 31 is a billable ICD code used to specify a diagnosis of encounter for screening mammogram for malignant neoplasm of breast. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Subsequently, question is, what is diagnosis code z1231? Z1231 - Encounter for screening mammogram for malignant neoplasm of breast - as a primary or secondary diagnosis code. Total National Projected Hospitalizations - Annualized (Present on Admission - All)
31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Effective from April 1, 2010, non-covered services should be billed with modifier –GA, -GX, -GY, or –GZ, as appropriate.
It is the responsibility of the provider to code to the highest level specified in the ICD-10-CM. The correct use of an ICD-10-CM code listed below does not assure coverage of a service. The service must be reasonable and necessary in the specific case and must meet the criteria specified in this determination.